LATEST

Off the Wire

IN FOCUS

Study Confirms Mastectomy Reduces Breast Cancer Risk in BRCA Carriers

A recent study conducted by Kelly Metcalfe and colleagues and published in the British Journal of Cancer in 2024, explores the effectiveness of risk-reducing mastectomy (RRM) in...

Tumor Cell ‘Homing’ and the Mastectomy vs. Lumpectomy Debate

Notable breast surgeon and researcher, Dr. Kefah Mokbel, is advocating the benefits of breast-conserving therapy over mastectomy in certain patients, based on a combination of clinical evidence...

Annual Breast Cancer Screening from Age 40 Proves Most Effective, CISNET Study Finds

The debate around the optimal strategy for breast cancer screening—concerning both the age at which women should begin screening and the frequency of these screenings—serves as the...

LEARN MORE

RESEARCH

RESEARCH

LEARN MORE

Study Unveils Cancer Causing Chemicals Among Women Workers

Breast cancer is a major health issue in California, being the most common and the second deadliest cancer among women in the state. Nearly...

Continued Trial of Trilaciclib Shows Promise in Extending Survival for Triple-Negative Breast Cancer

The next phase of an important trial for metastatic triple-negative breast cancer patients is evaluating the effectiveness of trilaciclib combined with chemotherapy. This effort, officially...

Turning Cancer’s Acidity Against Itself Without Harming Healthy Tissue

A team of researchers from Vanderbilt University and Vanderbilt University Medical Center has developed a groundbreaking method to destroy tumors by disrupting their acidic...

Study Links Air Pollution to More Severe Breast Cancer Cases

A groundbreaking study has revealed a concerning connection between air pollution and the severity of breast cancer, shedding light on how our environment could...

Nanotechnology-Enhanced Resveratrol Shows Promise in Treatment of Triple-Negative Breast Cancer

Yes, it's that kind of resveratrol--that found in red wine. But with a technical twist to ensure it's delivered properly. Triple-negative breast cancer (TNBC) is...

DRUG DEVELOPMENT